Opus Genetics
IRD • XNAS
Opus Genetics is a pharmaceutical preparations company trading on XNAS, led by CEO George Magrath, with a market cap of $309.5M.
CEOGeorge Magrath
Next Earnings
Upcoming earnings announcement for Opus Genetics
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.16
Revenue Estimate
$3.0M
Earnings History
Past 6 earnings reports for Opus Genetics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.21Est: -$0.10 | -110.0% | $3.9MEst: $2.9M | +31.4% | — |
| Nov 12, 2025 | Q3 2025 | -$0.25Est: -$0.13 | -92.3% | $3.1MEst: $3.0M | +4.1% |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.12Est: -$0.26 | +53.8% | $2.9MEst: $3.9M | -25.6% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.24Est: -$0.29 | +17.2% | $4.4MEst: $4.0M | +9.3% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$1.27 | — | $4.3M | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.29 | — | $3.9M | — | 10-Q |